[1]
A. Peters, T. Mehta, and R. Govindarajan, “Clinical Experience of Edaravone in Amyotrophic Lateral Sclerosis ”, rrnmf, vol. 1, no. 2, pp. 3–6, Jun. 2020, doi: 10.17161/rrnmf.v1i2.13554.